Cosmos Health (COSM) Total Liabilities (2011 - 2026)
Cosmos Health's (COSM) quarterly Total Liabilities came in at $40.8 million in Q2 2026, up 14.56% on a YoY basis from $35.6 million in Q2 2025, and down 4.13% quarter-over-quarter from $42.5 million in Q1 2026.
Analysis
Cosmos Health (COSM) Total Liabilities (2011 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Total Liabilities for 16 consecutive years, with $40.8 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Liabilities rose 14.56% year-over-year to $40.8 million; the trailing twelve-month figure through Jun 2026 stood at $40.8 million (up 14.56% YoY), and the FY2025 full-year result was $47.1 million, up 58.01% from the prior year.
- Total Liabilities eased to $40.8 million in Q2 2026 per COSM's latest filing, from $42.5 million in the prior quarter.
- Across five years, Total Liabilities topped out at $47.1 million in Q4 2025 and bottomed at $23.6 million in Q1 2023.
- Historically, Total Liabilities has averaged $34.0 million across 5 years, with a median of $30.6 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Total Liabilities tumbled 39.66% in 2023, then jumped 58.01% in 2025.
- Over 5 years, Total Liabilities stood at $28.4 million in 2022, then advanced by 5.6% to $30.0 million in 2023, then declined by 0.64% to $29.8 million in 2024, then soared by 58.01% to $47.1 million in 2025, then retreated by 13.32% to $40.8 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $40.8 million, $42.5 million, and $47.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 32.10 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 20.78 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 1.99 Bn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 3.74 Bn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 25.60 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 1.78 Bn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 896.90 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 975.61 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 33.31 Mn |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | 40.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.79 Mn |
| Mar 31, 2026 | 42.54 Mn |
| Dec 31, 2025 | 47.05 Mn |
| Sep 30, 2025 | 46.36 Mn |
| Jun 30, 2025 | 35.60 Mn |
| Mar 31, 2025 | 31.24 Mn |
| Dec 31, 2024 | 29.78 Mn |
| Sep 30, 2024 | 29.54 Mn |
| Jun 30, 2024 | 28.71 Mn |
| Mar 31, 2024 | 27.80 Mn |
| Dec 31, 2023 | 29.97 Mn |
| Sep 30, 2023 | 26.96 Mn |
| Jun 30, 2023 | 24.55 Mn |
| Mar 31, 2023 | 23.64 Mn |
| Dec 31, 2022 | 28.38 Mn |
| Sep 30, 2022 | 40.47 Mn |
| Jun 30, 2022 | 39.69 Mn |
| Mar 31, 2022 | 39.17 Mn |
| Dec 31, 2021 | 45.05 Mn |
| Sep 30, 2021 | 43.03 Mn |